What regulatory guidelines apply to Astragalus Metabolite 8 (Cladrin) (CAS: 24160-14-3)?

Astragalus Metabolite 8 (Cladrin) (CAS: 24160-14-3) should follow the regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), including health, environmental, and physical hazards. In the European Union, it falls under the REACH regulations, requiring registration and compliance with specific handling and reporting procedures. FDA regulations for the U.S. market may include specific labeling and reporting standards for certain uses, and EPA guidelines for environmental protection should also be adhered to.